TWST News and Press, Twist Bioscience Corporation From 05/30/23

2023-05-30 17:31:44 ET Gainers: Extreme Networks ( EXTR ) +6% . Elevation Oncology ( ELEV ) +6% . Annexon ( ANNX ) +4% . Twist Bioscience Corporation ( TWST ) +4% . Omeros Corporation ( OMER ) +4% . Losers: Ambarella ( ...

2023-05-24 11:27:03 ET Summary Twist's moderate growth and large losses continue to place downward pressure on the stock. Twist is increasing its focus on profitability, but the shift in strategy also raises questions about the growth outlook. If Twist can continue to grow its...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Robert Werner as chief accounting officer. “Rob has a proven track record of leading ...

Includes Twist RNA Exome, target enrichment for RNA and whole transcriptome sequencing Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a ...

2023-05-19 13:28:28 ET Summary The stock of Twist Bioscience Corporation has declined more than 60% since our first peek at it in the fall of last year. However, the stock saw its first insider buy in a year last week, and the company is restructuring its organization to lower cos...

2023-05-15 12:03:23 ET Twist Bioscience Corporation ( NASDAQ: TWST ) added ~16% on Monday to mark the biggest intraday gain since November after its senior vice president Dennis Cho disclosed the purchase of 10K shares of the synthetic biology company. According to a regul...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at Imec Technology Forum (ITF) ...

2023-05-05 12:31:05 ET Twist Bioscience Corporation (TWST) Q2 2023 Earnings Conference Call May 05, 2023, 08:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs and ESG Officer Emily Leproust - CEO and Co-Founder James Thorburn - CFO Confe...

2023-05-04 12:36:33 ET Twist Bioscience ( NASDAQ: TWST ) is scheduled to announce FQ2 earnings results on Friday, May 5th, before market open. The consensus EPS Estimate is -$1.10 (+2.7% Y/Y) and the consensus Revenue Estimate is $56.59M (+17.6% Y/Y). Over the last 2 y...

2023-04-27 11:52:07 ET Twist Bioscience ( NASDAQ: TWST ) and Aster Insights are launching a next generation oncology panel AsterExome for cancer research. The company said the panel can simultaneously enable whole exome sequencing (WES) with additional coverage for target regi...